Add like
Add dislike
Add to saved papers

Diagnostic ability of the Heidelberg Retina Tomograph 3 for glaucoma.

PURPOSE: To compare the diagnostic ability of the Heidelberg Retina Tomograph 3 (HRT3) and the Heidelberg Retina Tomograph 2 (HRT2) for discriminating between healthy eyes and eyes with glaucomatous visual field loss.

DESIGN: Retrospective cross-sectional study.

METHODS: Participants were 93 healthy subjects and 90 patients with open-angle glaucoma. All participants underwent imaging of the optic nerve head with the HRT2. Afterward, HRT data also were analyzed using version 3 of the software without modifying the optic disk contour line. The receiver operating characteristic (ROC) curves between normal and glaucomatous subjects were plotted for the global stereometric parameters of both software versions. Moorfields regression analysis (MRA) and glaucoma probability score (GPS) diagnostic abilities also were compared.

RESULTS: The parameters with the largest areas under the ROC curve were the Frederick S. Mikelberg (FSM) discriminant function for the HRT3 (0.948) and the vertical cup-to-disk ratio (0.914) for the HRT2. At a fixed specificity of 95%, the best sensitivity was 74.4% for the Reinhard O.W. Burk (RB) discriminant function of the HRT2 and 83.3% for the FSM discriminant function of the HRT3. The best sensitivity and specificity pairs for the HRT classifications were 85.5% and 76.3%, respectively, for overall MRA2, 84.4% and 83.8%, respectively, for overall MRA3, 93.3% and 58.0%, respectively, for the global color-coded GPS, and 84.4% and 74.1%, respectively, for the global GPS numerical value.

CONCLUSIONS: At 95% fixed specificity, most HRT3 parameters exhibited at least the same sensitivity for glaucoma diagnosis as the analogous parameters for the HRT2. The diagnostic ability overall of MRA3 was similar to that of the previous version. GPS exhibited higher sensitivity and somewhat lower specificity than the MRA.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app